A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia

Waldenström macroglobulinemia (WM) is a slowly progressing B-cell non-Hodgkin lymphoma characterized by monoclonal IgM gammopathy in the blood and infiltration of the bone marrow by clonal lymphoplasmacytic cells. As an incurable disease, the goals for therapy for WM are to relieve symptoms, slow di...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Rayan Kaedbey, Nicholas Forward, Laurie H. Sehn, Mona Shafey, Sarah Doucette, Christine I. Chen
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Subjects:	Waldenström macroglobulinemia chemoimmunotherapy Bruton’s tyrosine kinase inhibitors
Online Access:	https://www.mdpi.com/1718-7729/29/10/560